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httpicense.Abstract New simple and sensitive spectrophotometric and spectroﬂuorimetric methods have been
developed and validated for the determination of saxagliptin (SAX) and vildagliptin (VDG) in bulk
and pharmaceutical preparations. The spectrophotometric methods were based on derivatization of
the investigated drugs with two reagents: 1,2-naphthoquinone-4-sulfonic acid sodium salt (NQS)
and 4-chloro-7-nitrobenzofurazan (NBD-Cl). For further increase in the sensitivity, the D1 spectra
of the reactions products were also recorded. For NQS reaction, Beer’s law was obeyed over the
ranges of 5–30 and 7–45 lg mL1 for the absorbance readings; and 3–32 and 5–50 lg mL1 for
the derivative readings of SAX and VDG, respectively. For NBD-Cl reaction, Beer’s law was
obeyed over the ranges of 3–20 and 4.5–35 lg mL1 for the absorbance readings; and 1.5–25 and
2.5–40 lg mL1 for the derivative readings of SAX and VDG, respectively. Spectroﬂuorimetric
methods were developed based on the fact that the derivatized investigated drugs with NBD-Cl
reagent are highly ﬂuorescent products. The ﬂuorescence concentration plots were linear over the
ranges of 0.02–0.25 and 0.03–0.37 lg mL1 for SAX and VDG, respectively. The ﬂuorescence mea-
surement enabled the detection of SAX and VDG at concentrations of about 3 and 7 ng mL1,
respectively. The proposed methods have been validated and successfully applied to the determina-
tion of the investigated drugs in their pharmaceutical preparations. The results obtained were sta-
tistically compared to those obtained from reference methods.
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Saxagliptin (SAX), (1S,3S,5S)-2-[(2S)-2-Amino-2-(3-hydroxy-
tricyclo [3.3.1.13,7]dec-1-yl)acetyl]-2-azabicyclo [3.1.0]
hexane-3-carbonitrile and Vildagliptin (VDG), ((2S)-1-[2-[(3-
hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carboni-
trile), are two novel oral hypoglycemic drugs of the dipeptidyl-
peptidase-4 (DPP-4) inhibitor class.1,2 DPP-4 inhibitors
represent a new therapeutic approach to the treatment of typeaculty of Pharmacy, Cairo University.
3.03.003
140 M.S. Moneeb2 diabetes mellitus. They inhibit the inactivation of incretins,
resulting in the stimulation of glucose-dependent insulin re-
lease and the reduction of glucagon levels.3 Few analytical
methods have been reported for the determination of the two
novel gliptins. SAX has been estimated in tablets simulta-
neously with either metformin4,5 or pioglitazone6 using RP-
HPLC. A liquid chromatography tandem mass spectrometry
method has been reported for the quantitative determination
of SAX and its major metabolite in human plasma.7 VDG
has been determined by few RP-LC methods in pharmaceuti-
cal preparations8,9 and in plasma.10 RP-LC has also been used
to estimate VDG simultaneously with metformin in dosage
forms.5,11
Among the various methods available for the quantitation
of drugs, spectrophotometry and spectroﬂuorimetry continue
to be the most convenient analytical techniques, because of
their inherent simplicity, low cost and wide availability in most
quality control laboratories. Chromatographic methods re-
quire highly sophisticated and expensive instruments and sol-
vents that may not be available in some quality control
laboratories in the developing countries. Literature review re-
vealed that no spectroﬂuorimetric method has been reported
for the determination of either SAX or VDG. Only two spec-
trophotometric methods have been reported for the estimation
of SAX in pure form and tablet formulation. In the ﬁrst meth-
od, SAX was directly estimated at 208 nm in methanol.12 The
second method was based on colorimetric determination after
charge transfer reactions with 2,3-dichloro-5,6dicyano-1,4-
benzoquinone (DDQ) and 7,7,8,8,tetracyanoquinodimethane
(TCNQ).13 Only one spectrophotometric method has been de-
scribed for the determination of VDG in bulk and dosage
forms. This method was based on the colorimetric determina-
tion after charge transfer reactions with 2,3-dichloro-5,
6dicyano-1,4-benzoquinone (DDQ); 7,7,8,8,tetracyanoquino-
dimethane (TCNQ) and tetra-chloro-1,4-benzoquinone
(p-chloranil).14
Due to the poorly absorbing chromophores in the exam-
ined drugs and their highly blue shifted kmax, their determina-
tion in their dosage forms based on the direct measurement of
their absorption for ultraviolet is susceptible to potential inter-
ferences from the co-extracted common excipients and/or
impurities. The problem is more aggravated if it is required
to determine these drugs in biological ﬂuids. Therefore, deriv-
atization is necessary for their determination. So, the aim of
the present work is to develop new simple, sensitive and spe-
ciﬁc color reactions for SAX and VDG and the employment
of these reactions in the development of new spectrophotomet-
ric and spectroﬂuorimetric methods for the determination of
both drugs in pharmaceutical formulations. These methods
can be considered as useful alternatives to reported methods.
They can overcome the drawbacks of the existing spectropho-
tometric methods and offer better sensitivity.
1,2-Naphthoquinone-4-sulfonic acid sodium salt (NQS)15–
17 and 4-chloro-7-nitrobenzofurazan (NBD-Cl)18–20 have been
used as derivatizing reagents in the development of both spec-
trophotometric and spectroﬂuorimetric methods for the deter-
mination of many pharmaceuticals bearing a primary or a
secondary amino group. SAX bearing a primary amino group
and VDG having a secondary amino group are potential
candidates for the reaction with both NQS and NBD-Cl.Therefore, the present study was devoted to investigate the
reaction of SAX and VDG with both reagents, and use these
color reactions in the development of simple and rapid spectro-
photometric and spectroﬂuorimetric methods for the determi-
nation of both drugs in pharmaceutical preparations.
2. Experimental
2.1. Apparatus
Spectrophotometric measurements were performed using a
Specord S600 diode-array spectrophotometer, associated with
WinAspect Software version 2.3, Analytik Jena AG, Germany.
Spectroﬂuorimetric measurements were carried out on a Schi-
madzu (Kyoto, Japan), model RF-1501 version 3.0 spectroﬂu-
orophotometer equipped with 1-cm quartz cell and a 150 W
xenon lamp. Thermostated water bath (Kotlermann Hanigsen,
Germany) and a Schott Gerate pH Meter CG 820 were used.
2.2. Reagents and reference materials
Pharmaceutical grade saxagliptin hydrochloride, certiﬁed to
contain 99.8% and Onglyza tablets (batch no: 1E6034B),
nominally containing 5.58 mg anhydrous saxagliptin hydro-
chloride equivalent to 5 mg SAX per tablet, were kindly sup-
plied from Bristol-Myers Squibb Company (Indiana, USA).
Pharmaceutical grade VDG, certiﬁed to contain 99.6% and
Galvus tablets (batch no: S0421A), nominally containing
50 mg VDG per tablet, were kindly supplied from Novartis
Pharma AG Co. (Basle, Switzerland).
A solution of 0.5% (w/v) of 1,2-naphthoquinone-4-sulfonic
acid sodium salt (NQS; Hopkin and Williams, Chadwell
Health, Essex, England) was prepared by dissolving 250 mg
in 50 mL distilled water. The solution was freshly prepared
and protected from light during use. A solution of 0.2%
(w/v) of 4-chloro-7-nitrobenzofurazan (NBD-Cl; Fluka,
Buchs, Switzerland) was freshly prepared by dissolving
100 mg in 50 mL methanol. 0.2 M alkaline borate buffer solu-
tions of pH values 8.5, 9, 9.5 and 10 were prepared by mixing
50 mL of 0.2 M aqueous solution of boric acid and potassium
chloride (1 L contains 12.37 g of boric acid and 14.91 g of
potassium chloride) with the speciﬁed volume of 0.2 M NaOH
in 200-mL volumetric ﬂask. The required volume was made up
with water and the pH is adjusted by pH meter.21 Hydrochlo-
ric acid solution, 4 M, was prepared. Doubly distilled water
was used throughout the work. All solvents and materials used
throughout this study were of analytical grade.
2.3. Preparation of standard solutions
SAX and VDG stock solutions (1 mg/mL) were prepared sep-
arately by dissolving 50 mg of each drug in 50-mL methanol.
Stock solutions were protected from light by aluminum foil
and kept refrigerated at 4 C. With respect to these storage
conditions, these solutions were found to be stable for at least
1 month. The stock solutions were further diluted with distilled
water (for reactions with NQS) or methanol (for reactions with
NBD-Cl) to obtain working solutions in the concentration
ranges speciﬁed in Table 1.
Table 1 Experimental parameters of the proposed spectrophotometric (absorbance and derivative) and spectroﬂuorimetric methods.
Parameter NQS NBD-Cl
SAX VDG SAX VDG
Working standard solutions (lg mL1) 30–320 50–500 15–250 25–400
pH and volume of borate buﬀer pH 10
1 mL
pH 9.5
1 mL
pH 9
1 mL
pH 8.5
1 mL
NQS/NBD-Cl (%w/v) 0.5% 0.5% 0.2% 0.2%
Temperature (C) 25 50 70 70
Reaction time (min) 10 10 15 20
Diluting solvent Water Water Methanol Methanol
Measuring wavelength kmax (nm) 475 470 470 468
Peak-trough D1(nm) 429.5–504.5 422.5–497.5 441.5–489.5 438.5–486.5
kem (kex) (nm) 542 (468) 540 (465)
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2.4.1. NQS method
2.4.1.1. Spectrophotometric measurement. One milliliter of the
standard working solutions of SAX and VDG (over the con-
centration ranges shown in Table 1) was transferred into
separate 10-mL calibrated ﬂasks. One mL of borate buffer
of appropriate pH (as indicated in Table 1) was added fol-
lowed by 1 mL of NQS solution. The reaction solution
was mixed well. That of SAX was allowed to proceed for
10 min at room temperature (25 C). That of VDG was al-
lowed to proceed for the same time at 50 C in a thermostat-
ically controlled water bath. The reaction mixture was then
made up to the required volume with water. The resulting
solution was measured at 475 and 470 nm for SAX and
VDG, respectively, against the corresponding reagents’ blank
treated similarly. The drug concentration was calculated
from the corresponding regression equation of the calibra-
tion graph.
2.4.1.2. Derivative spectrophotometric measurement. Sticking to
the abovementioned procedure, the D1 spectra of the devel-
oped colors were recorded and the peak-trough amplitudes
at 429.5–504.5 and 422.5–497.5 nm for SAX and VDG, respec-
tively, were computed.
2.4.2. NBD-Cl method
2.4.2.1. Spectrophotometric measurement. One milliliter of the
standard working solutions of SAX and VDG (over the con-
centration ranges shown in Table 1) was transferred into sep-
arate 10-mL calibrated ﬂasks. One mL of borate buffer of
appropriate pH (as indicated in Table 1) was added followed
by 1 mL of NBD-Cl solution. The reaction solution was mixed
well and placed in a thermostatically controlled water bath at
70 C for a ﬁxed time of 15 min (for SAX) and at the same
temperature for a ﬁxed time of 20 min (for VDG). The reaction
mixture was quenched by cooling under tap water. Then, it
was acidiﬁed by adding 0.1 mL of 4 M hydrochloric acid solu-
tion, and completed to volume with methanol. The absorbance
of solutions was measured at 470 and 468 nm for SAX and
VDG, respectively, against the corresponding reagents’ blank
treated similarly. The drug concentration was calculated from
the corresponding regression equation of the calibration
graph.2.4.2.2. Derivative spectrophotometric measurement. Sticking to
the abovementioned procedure, the D1 spectra of the devel-
oped colors were recorded and the peak-trough amplitudes
at 441.5–489.5 and 438.5–486.5 nm for SAX and VDG, respec-
tively, were computed.
2.4.2.3. Spectroﬂuorimetric measurement. Aliquots of SAX and
VDG reaction mixtures prepared for the spectrophotometric
measurement were diluted with methanol to reach the concen-
tration ranges speciﬁed in Tables 2 and 3. The relative ﬂuores-
cence intensity (RFI) of the resulting solutions was measured
at the appropriate excitation and emission wavelengths (Ta-
ble 1). The measured RFI was plotted versus the ﬁnal concen-
tration to obtain the calibration graph. The drug
concentration was calculated from the corresponding regres-
sion equation of the calibration graph.
2.4.3. Procedure for commercial tablets
Twenty tablets of each formulation were separately weighed.
The coats of Onglyza were removed by carefully rubbing with
a clean tissue wetted with methanol. The tablets were separately
ﬁnely powdered. An accurately weighed amount of each tablet
powder equivalent to 100 mgof the corresponding drugwas sep-
arately transferred into 100-mL calibrated ﬂasks, and dissolved
in about 40-mL of methanol. The contents of the ﬂasks were
swirled, sonicated for 20 min, and then made up to the required
volumewith the same solvent. The contents weremixedwell and
ﬁltered rejecting the ﬁrst portion of the ﬁltrate. The prepared
solutions were diluted quantitatively with distilled water (for
reactions with NQS) or methanol (for reactions with NBD-Cl)
to obtain suitable concentration for the analysis. Aliquots of
the tablets solutions were treated as under the general recom-
mended procedures for the reaction with NQS and NBD-Cl.
2.5. Determination of the stoichiometric ratio of the reaction
The stoichiometric ratio of the formed products was investi-
gated by Job’s continuous variation method.22 Equimolar
stock solutions of each drug, NQS and NBD-Cl were prepared
in the previously speciﬁed solvents. The drug and both re-
agents were prepared as 3.17 · 103 and 3.30 · 103 M for
SAX and VDG, respectively. Series of 5-mL portions of the
stock solutions of the drug and the reagent were made up com-
prising different complementary proportions (0:10, 1:9, . . .. . ...
Table 2 Analytical parameters for the proposed spectrophotometric and spectroﬂuorimetric methods for the determination of SAX.
Parameter NQS NBD-Cl
A D1 A D1 F
Linear range lg mL1 5–30 3–32 3–20 1.5–25 0.02–0.25
Regression parameters
a 2.0 · 103 1.7 · 103 1.1 · 103 0.7 · 103 0.82
b 0.0401 0.0534 0.0633 0.0391 3500
r 0.99995 0.99997 0.99996 0.99997 0.99985
Sa 1.1 · 10–3 0.9 · 103 5.8 · 104 3.4 · 104 0.41
Lower 95%a 0.0011 0.0008 0.0005 0.0002 1.9598
Upper 95%a 0.0051 0.0042 0.0027 0.0016 0.3198
Sb 4.0 · 104 3.5 · 104 5.1 · 104 4.9 · 104 28
Sy/x 1.4 · 103 1.2 · 103 6.0 · 104 3.5 · 104 0.89
LODb 1.00 0.48 0.56 0.27 0.003
LOQb 3.01 1.45 1.68 0.80 0.01
a Lower and upper conﬁdence limits for the intercept at the 95% conﬁdence level.
b Concentrations are in lg mL1.
Table 3 Analytical parameters for the proposed spectrophotometric and spectroﬂuorimetric methods for the determination of VDG.
Parameter NQS NBD-Cl
A D1 A D1 F
Linear range lg mL1 7–45 5–50 4.5–35 2.5–40 0.03–0.37
Regression parameters
a 1.8 · 103 1.5 · 103 1.4 · 103 1.0 · 103 0.95
b 0.0286 0.0383 0.04 0.0248 2400
r 0.99993 0.99994 0.99998 0.99999 0.99972
Sa 1.45 · 103 1.10 · 103 1.00 · 103 1.20 · 103 0.44
Lower 95%a 0.0058 0.0046 0.0014 0.0023 0.2732
Upper 95%a 0.0022 0.0016 0.0042 0.0043 2.1732
Sb 2.6 · 104 2.2 · 104 2.8 · 104 2.7 · 104 20
Sy/x 1.61 · 103 1.15 · 103 1.50 · 103 1.82 · 103 0.93
LODb 1.84 1.03 1.04 0.32 0.007
LOQb 5.52 3.08 3.12 0.95 0.02
a Lower and upper conﬁdence limits for the intercept at the 95% conﬁdence level.
b Concentrations are in lg mL1.
142 M.S. Moneeb9:1, 10:0, inclusive) in 10-mL calibrated ﬂasks containing 1 mL
of the appropriate buffer. The solutions were further manipu-
lated as described under the general recommended procedures
described above. The absorbance/RFI of each solution was
plotted against the drug mole fraction [drug]/[drug] +
[reagent].3. Results and discussion
3.1. Absorption, derivative and ﬂuorescence spectra
The absorption of SAX and VDG was separately recorded
against water (Figs. 1 and 2). It was found that the maximum
absorption peaks (kmax) of both drugs were 208 and 203 nm
and their molar absorptivities (e) were 8.32 · 103 and
7.81 · 103 L mol1 cm1 for SAX and VDG, respectively. Be-
cause of the highly blue shifted kmax of both drugs, their deter-
mination in the pharmaceutical formulations based on the
direct measurement of their absorption of ultraviolet light is
susceptible to potential interferences from the co-extractedcommon excipients. As well the low e value could ultimately
result in poor sensitivity. Therefore, derivatization of both
drugs to more red shifted light absorbing derivatives was nec-
essary. The reaction between both drugs and NQS/NBD-Cl
was performed. The absorption spectra of the products were
recorded against reagents’ blank. For the reaction with NQS,
the products were orange-colored exhibiting kmax at 475 and
470 nm for SAX and VDG, respectively (Figs. 1 and 2). For
the reaction with NBD-Cl, the products were yellow-colored
exhibiting kmax at 470 and 468 nm for SAX and VDG, respec-
tively (Figs. 1 and 2). Obviously, the kmax of the products was
highly red shifted. This could ultimately eliminate any poten-
tial interference. As well, the sensitivity (e) was greatly en-
hanced to be 1.89 · 104 and 3.03 · 104 L mol1 cm1 for
SAX; and 1.31 · 104 and 1.87 · 104 L mol1 cm1 for VDG
using NQS and NBD-Cl reagents, respectively. Therefore,
the spectrophotometric measurements were carried out at
475 and 470 nm for SAX; and 470 and 468 nm for VDG using
NQS and NBD-Cl, respectively. For further increase in the
sensitivity, the D1 spectra of the reactions products were also
recorded and the peak-trough amplitudes at 429.5–504.5 and
Figure 1 Absorption spectra of 10 lg mL1 SAX against water (1), its reaction product with NQS against reagent blank (2), and its
reaction product with NBD-Cl against reagent blank (3). First derivative spectra of its reaction product with NQS (4) and NBD-Cl (5)
against reagents blank.
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for VDG using NQS and NBD-Cl, respectively, were mea-
sured (Figs. 1 and 2).
SAX and VDG do not have a native ﬂuorescence, thus their
derivatization with ﬂuorogenic reagent was necessary for their
ﬂuorimetric determination. The reaction between SAX/VDG
and NBD-Cl was performed for this purpose. The derivatives
exhibited maximum ﬂuorescence intensity at kem of 542 and
540 nm after their excitation at kex of 468 and 465 nm for
SAX and VDG, respectively. The excitation and emission
spectra of the reaction products of SAX/VDG with NBD-Cl
are given in Fig. 3.
3.2. Optimization of reactions variables
Different experimental parameters affecting the color
development and its stability were carefully studied andoptimized. Such factors were changed individually while
keeping others constant. These factors include reagent
concentration, pH, temperature, time and diluting
solvent.3.2.1. Effect of reagent concentration
The effect of NQS and NBD-Cl concentrations on their reac-
tions with SAX/VDG revealed that the reactions were depen-
dent on the reagent concentration. It was found that for both
SAX and VDG, increasing the reagent concentration in-
creased the color intensity, up to 0.3% and 0.1% (w/v) for
NQS and NBD-Cl, respectively (Fig. 4). Beyond these values,
no more increase in absorbance was attained. For high pre-
cise values, further experiments of both drugs were carried
out using 0.5% and 0.2% (w/v) for NQS and NBD-Cl,
respectively.
Figure 2 Absorption spectra of 10 lg mL1 VDG against water (1), its reaction product with NQS against reagent blank (2) and its
reaction product with NBD-Cl against reagent blank (3). First derivative spectra of its reaction product with NQS (4) and NBD-Cl (5)
against reagents blank.
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To generate the nucleophile from SAX/VDG and activate the
nucleophilic substitution reaction, alkaline medium was neces-
sary. The inﬂuence of pH on the reaction of SAX/VDG with
both reagents was studied and optimized to obtain maximum
color intensity (Fig. 5). The pH was varied over the pH range
of 7–11 using 0.2 M borate buffer. Upon increasing the pH,
higher absorbance values were obtained with maximum absor-
bance at pH values 10 and 9 for SAX; and 9.5 and 8.5 for
VDG using NQS and NBD-Cl, respectively. At higher pH val-
ues, a sharp decrease in the readings occurred. This was attrib-
uted probably to the increase in the concentration of
hydroxide ion that holds back the reaction of the investigated
drugs with both reagents.15,16 At pH 0–6, the absorbance of
the product is close to 0. The possible reason may be that
the amino group is protonized and turned into protonated
amine salt. So, it loses nucleophilic capability, and the nucleo-
philic substitution reaction cannot take place easily.15 Other
buffers having the same pH values such as phosphate bufferand citric acid-phosphate (Mcllvaine’s buffer) were tested. Bo-
rate buffer was found to be superior because it resulted in more
stable highly colored solutions. Also some inorganic bases
were tried like sodium hydroxide, borax and disodium hydro-
gen phosphate, all prepared as aqueous solutions of a concen-
tration range of 0.1–0.5 M. Unfortunately, high blank readings
and/or non-reproducible results were observed with them.
3.2.3. Effect of temperature and time
The effect of temperature was studied over the range of 20–
90 C with constant heating time. It was found that the reac-
tion of SAX with NQS was negligibly affected by raising the
temperature. Maximum absorbance reading was attained in
10 min at room temperature (25 C). Longer reaction time
up to 30 min did not affect the reaction. Heating the reaction
mixture in the range of 40–50 C had slight positive effect on
the reaction. However, to simplify the procedure, further
experiments of SAX with NQS reagent were carried out at
room temperature (25 C) for 10 min. The reaction of VDG
Figure 3 Excitation (1) and emission (2) spectra of the reaction product of (0.2 lg mL1) SAX and VDG with NBD-Cl in methanol.
Figure 4 Effect of NQS and NBD-Cl concentrations on their reactions with SAX (20 and 10 lg mL1) and VDG (30 and 20 lg mL1),
respectively.
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quired 40 min for completion. Increasing the temperature of
the water bath produced an increase in the product absorbanceup to 40 C. Above which, almost constant absorbance values
were obtained. Maximum absorbance reading was attained in
10 min at 40 C. Longer heating time, up to 30 min, did not
Figure 5 Effect of pH on the reaction of SAX (20 and 10 lg mL1) and VDG (30 and 20 lg mL1) with NQS and NBD-Cl, respectively.
Figure 6 Effect of temperature and time on the reaction of SAX (20 and 10 lg mL1) with NQS and NBD-Cl, respectively.
146 M.S. Moneebaffect the reaction. Therefore, for high precise values, further
experiments of VDG with NQS reagent were carried out at
50 C for 10 min.
The reaction of SAX and VDG with NBD-Cl has not been
completed at room temperature (25 C) for at least 1 h.
Increasing the temperature of the water bath up to 70 C pro-
duced an increase in the absorbance of the reaction product.
Beyond this temperature, almost constant readings were ob-
tained. Proceeding the reactions at 70 C for varying time
intervals revealed that maximum readings were attained by
heating at 70 C for 10 and 15 min for SAX and VDG, respec-
tively. Heating for longer periods up to 40 min had a negligible
effect on the obtained readings. So, for high precise values, fur-
ther experiments of SAX and VDG with NBD-Cl reagent were
carried out at 70 C for 15 and 20 min, respectively (Figs. 6
and 7).3.2.4. Effect of diluting solvent
Different solvents, such as water, acetone, methanol, ethanol,
isopropanol, acetonitrile and 1,4-dioxane were tested as poten-
tial diluting media. For NQS reactions, water was found to be
the optimum solvent for both drugs, as the highest absorbance
values were obtained. For NBD-Cl reactions, the highest read-
ings were obtained when methanol was used for dilution. With
NBD-Cl, signiﬁcantly high absorbance and ﬂuorescence back-
grounds were observed. This was attributed to the hydrolysis of
NBD-Cl to the corresponding hydroxy derivative, namely,
4-hydroxy-7-nitrobenzo-2-oxa-1,3-diazole (NBD-OH).23 The
readings of NBD-OH were found to be quenched by decreasing
the pH of the reaction mixture to less than one.24 Therefore,
acidiﬁcation of the reaction medium prior to dilution and mea-
surement of absorbance or ﬂuorescence was necessary. This re-
sulted in a signiﬁcant decrease in the reagent blank color
Figure 7 Effect of temperature and time on the reaction of VDG (30 and 20 lg mL1) with NQS and NBD-Cl, respectively.
Figure 8 Scheme for the reactions pathways of SAX with NQS and NBD-Cl.
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the reaction product. Hence, the sensitivity was enhanced. This
step was accomplished by the addition of 0.1 mL of 4 M hydro-
chloric acid solution to the reaction mixtures of both drugs.
3.2.5. Stability of the chromophores and ﬂuorophores
Under the aforementioned optimum conditions, it was found
that the absorbance of the chromophores (SAX-NQS, VDG-
NQS, SAX-NBD-Cl and VDG-NBD-Cl) and the RFI of the
ﬂuorophores (SAX-NBD-Cl and VDG-NBD-Cl) remained
stable for at least 4 h at an ambient temperature and at least
for 48 h when kept at 4 C in the dark. This allowed the pro-
cessing of large batches of samples, and their comfortable mea-
surements with convenience.
3.3. Stoichiometry of the reactions
Under the optimum conditions, the stoichiometry of the reac-
tions between SAX and VDG was investigated by Job’smethod.22 The symmetrical bell shape of Job’s plot (not shown
data) indicated that the drug: reagent ratio was 1:1 for both
drugs using both reagents. This ratio was expected as the inves-
tigated drugs contain only one center (primary amino group in
SAX and secondary amino group in VDG) available for the
reaction. Based on this ratio, the reactions’ pathways were pos-
tulated to be proceeded as shown in Figs. 8 and 9. The primary
amino group in SAX and the secondary amino group in VDG
exhibit nucleophilic character in alkaline medium due to the
availability of the lone pair of electrons on the nitrogen atom.
By examining NQS structure, it is clear that C4 (attached to the
sulfonic group) is an electron deﬁcient center due to the pres-
ence of C3–4 double bond in conjugation with the C2 carbonyl
group. Therefore, through nucleophilic substitution reaction15,
SAX and VDG can react with NQS forming intensely orange-
colored products. Both drugs can react with NBD-Cl too
forming intensely yellow-colored products. Such reaction pro-
ceeds through the nucleophilic substitution of the chloride
atom of the reagent.18
Figure 9 Scheme for the reactions pathways of VDG with NQS and NBD-Cl.
Table 4 Accuracy and precision of the proposed methods for
the determination of SAX.
Method Accuracy Precision
% Mean
recoverya
Intra-day
RSD %
Inter-day
RSD %
NQS lg mL1
A 5 100.3 0.51 0.73
15 99.4 0.55 0.64
30 100.8 0.69 0.86
D1 3 99.7 0.46 0.60
15 99.9 0.52 0.69
30 100.4 0.40 0.51
NBD-Cl lg mL1
A 3 99.6 0.64 0.78
10 100.2 0.57 0.85
20 100.0 0.43 0.61
D1 2 100.1 0.39 0.56
10 99.5 0.48 0.67
20 99.9 0.54 0.71
F 0.02 99.5 0.74 0.92
0.10 99.0 0.71 0.96
0.20 100.3 0.63 0.84
a Each result is the mean of ﬁve experiments.
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3.4.1. Linearity
For each of the proposed methods, a series of six concentra-
tions of SAX/VDG standard solutions prepared in triplicate
was derivatized as previously described. Calibration curves
were constructed by plotting the measured response as a func-
tion of the corresponding concentration. Linearities for all
methods were calculated using the least squares regression
model. Regression parameters of the developed assays are
summarized in Tables 2 and 3. Other statistical parameters,
namely standard deviation of the intercept (Sa), slope (Sb)
and the residuals (Sy/x) were calculated as well (Tables 2 and
3). The good linearity of the calibration graphs and the negli-
gible scatter of the experimental points are clearly evident by
the high values of the correlation coefﬁcients, low intercepts
and standard deviations. To test if the intercept is differing sig-
niﬁcantly from zero, its conﬁdence limits at 95% signiﬁcance
level are determined (the conﬁdence limits for the intercept
are given by a± t(n2)sa).
25 For all the proposed calibrations,
the 95% conﬁdence interval of the intercept includes the ideal
value of zero (Tables 2 and 3).
3.4.2. Detection and quantitation limits
In accordance with the recommendations of ICH26, the limit of
detection, LOD= 3.3 r/s, where r is the standard deviation of
replicate determinations of the blank and s is the sensitivity,
namely the slope of the calibration graph. The limit of quanti-
tation, LOQ, is deﬁned as 10 r/s. The LOD and LOQ of the
proposed methods are presented in Tables 2 and 3. Obviously,
the LOD and LOQ values are lower for the spectroﬂuorimetric
methods due to the higher sensitivity of this technique.3.4.3. Accuracy and precision
Five replicate determinations at three different concentration
levels were carried out on the same day and for three consec-
utive days to test the accuracy, repeatability (intra-day preci-
sion) and intermediate precision (inter-day precision) of the
proposed methods. As shown in Tables 4 and 5, the %
Table 5 Accuracy and precision of the proposed methods for
the determination of VDG.
Method Accuracy Precision
% Mean
recoverya
Intra-day RSD % Inter-day RSD %
NQS lg mL1
A 7 99.4 0.70 0.91
20 101.0 0.42 0.73
40 99.8 0.61 0.84
D1 5 99.7 0.62 0.80
25 99.3 0.53 0.82
50 100.5 0.49 0.67
NBD-Cl lg mL1
A 5 100.2 0.56 0.81
15 99.0 0.44 0.79
30 99.5 0.39 0.60
D1 3 99.6 0.42 0.67
20 99.9 0.31 0.54
40 100.7 0.38 0.62
F 0.03 99.9 0.81 1.01
0.20 100.4 0.86 1.13
0.30 99.3 0.79 1.25
a Each result is the mean of ﬁve experiments.
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precision of the methods.
3.4.4. Speciﬁcity
The speciﬁcity of the methods was evaluated by investigating
the interference liabilities from the common excipients that
might be added during pharmaceutical formulation. Samples
were prepared by mixing known amounts (5 mg SAX/50 mg
VDG) with various amounts of the common excipients: starch
(50 mg), glucose (10 mg), lactose (10 mg), acacia (10 mg), talc
(5 mg) and magnesium stearate (10 mg). These laboratory pre-
pared samples were analyzed by the proposed methods apply-
ing the general recommended procedures previously
mentioned. Good recoveries of both drugs ranging from
99% to 101% with RSD % ranging from 0.5% to 0.9% wereTable 6 Application of the proposed methods to the determination
NQS N
A D1 A
Onglyza
Mean found %b 100.25 100.29 1
±SD 0.65 0.51
Variance 0.42 0.26
t (2.31)c 0.14 0.22
F (6.39)c 3.02 4.91
Galvus
Mean found %b 99.90 100.01 1
±SD 0.54 0.49
Variance 0.29 0.24
t (2.31)c 0.76 0.42
F (6.39)c 1.73 1.43
a Spectrophotometric methods using TCNQ.13,14
b Values are mean of ﬁve determinations.
c Figures in parentheses are the tabulated t and F values at p= 0.05.obtained. This conﬁrmed the absence of interference from any
of the common excipients with the determination of SAX/
VDG by the proposed methods.
3.4.5. Robustness
The robustness of the developed methods was examined by
evaluating the inﬂuence of small but deliberate variations of
the reaction conditions.21,26 One parameter was changed at a
time, whereas all others were kept constant. Variation of the
reagent volume by ±0.2 mL, buffer pH by ±0.2 pH units,
heating temperature by ±5 C, reaction time by ±5 min and
measurement wavelength by ±2 nm did not signiﬁcantly affect
the developed methods. This provided an indication for the
reliability of the proposed methods during their routine appli-
cation for the analysis of SAX/VDG.
3.5. Assay of pharmaceutical preparations
The proposed methods were applied to the analysis of com-
mercially available tablets. The amount of SAX/VDG was cal-
culated from the regression equation of the calibration curves.
Satisfactory results were obtained for each compound in good
agreement with the label claim as shown in Table 6. The results
were statistically compared to those obtained by the reference
methods13,14 with respect to the accuracy (t-test) and precision
(F-test). The values of the calculated t and F at 95% conﬁdence
level were less than the tabulated ones. This revealed that there
was no signiﬁcant difference with respect to accuracy and pre-
cision between the proposed methods and the reported ones.
4. Conclusion
The present paper described the successful evaluation of NQS
and NBD-Cl as analytical reagents in the development of sim-
ple, rapid, selective and sensitive spectrophotometric and spec-
troﬂuorimetric methods for the determination of SAX and
VDG in bulk and pharmaceutical preparations. In contrast
with the previously reported methods, the developed methods
in this work have many advantages: they do not need expen-
sive sophisticated apparatus; they are simple and rapid; theyof SAX and VDG in their pharmaceutical preparations.
BD-Cl Ref.a
D1 F
00.11 100.03 100.40 100.17
0.60 0.49 0.70 1.13
0.36 0.24 0.49 1.28
0.10 0.25 0.39
3.55 5.32 2.61
00.22 100.25 99.80 100.13
0.40 0.37 0.69 0.41
0.16 0.14 0.48 0.17
0.73 1.01 1.92
1.05 1.23 0.35
150 M.S. Moneebhave high sensitivity; and they are devoid of any potential
interference. Furthermore, the used analytical reagents are
inexpensive; have excellent shelf life; and are available in any
analytical laboratory. Therefore, the proposed methods can
readily be applied to routine quality control testing of SAX
and VDG. The described spectroﬂuorimetric methods are the
ﬁrst ﬂuorimetric methods for the analysis of the investigated
drugs. Due to the remarkably high sensitivity of these ﬂuori-
metric methods, further studies should be directed toward their
application to the analysis of the investigated drugs in biolog-
ical samples.
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None.
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